Data & services

Medicine shortages

When a medicine is short, the national medicines agency usually says so, but each country publishes its notices in its own place, language and format, and many remove a notice once the problem ends. MPA collects the national notices across Europe, translates the reasons, matches each notice to the licence and pack it concerns and keeps ended notices for a year, so a supply problem can be read across markets and against the product's licences and prices.

What it holds

  • The shortage notices published by national medicines agencies, pack by pack, with the product, active substance, strength, form and company.
  • The type of notice: a temporary shortage, a discontinuation where the source says the product will not return, or a product listed as at risk or restricted from export.
  • The dates as the source gives them: start, expected end, and when the source says the problem ended or stopped listing it.
  • The reason as published, in the original wording and in English.
  • Each notice matched to the national licence and pack it concerns, so it reads alongside the licences and prices for the same product.
  • Ended notices kept for twelve months, so a product that has been short recently can be seen even after the national list drops it.
Markets
Most EU and EEA countries, with more added as each national list is brought in. The UK is not included.
Not included
Stock levels and wholesaler availability. The dataset holds what the national authorities publish, not what is in the supply chain.

Who uses it, and why

Questions it answers

  • Is this product short anywhere in Europe right now, and in which packs?

  • Is it a temporary shortage or a discontinuation?

  • When is the shortage expected to end, and has the source said it has?

  • Which countries list this product as at risk or restrict its export?

  • What reason did the authority give?

  • Has this product been short in the last year, even if the national list no longer shows it?

  • Which products in our range have a supply notice somewhere in Europe?

How it is searched

Assessing a product

  1. 1Search by substance, product or company.
  2. 2Read the notices country by country: the type, the dates, the reason in English and in the original, and the pack concerned.
  3. 3Narrow to current notices, or include those that ended in the last twelve months.
  4. 4If you also subscribe to the other datasets, read the licence holders and the published prices for the same product alongside.

Finding opportunities

  1. 1Work through a whole list of products in one go: your sourcing range, a tender list or a therapeutic class.
  2. 2Filter to export-restricted and at-risk products before planning a sourcing route.
  3. 3Find discontinuations and long-running shortages where an alternative supplier could be needed.
  4. 4Add prices and parallel import licences to see whether a supply gap can be met, and from where.

Expert support, included

A notice shows what an authority published, not what it means for your supply. Whether an export restriction covers your route, how a national list defines a shortage, and what has changed since the notice are questions we answer as part of every subscription.

What to read first

All resources

See MPA Search in action

A free online demonstration with our team, with time for your questions.

Book a free demonstration